Travoprost Ophthalmic Solution Solution/ Drops
Product Images NDC 68083-602

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic Solution (NDC 68083-602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Travoprost-chemical-structure (Travoprost Chemical Structure)

Travoprost-chemical-structure (Travoprost Chemical Structure)
Chemical structure of travoprost, the active ingredient in Travoprost Ophthalmic Solution 0.04 mg/mL by Gland Pharma Limited. The diagram shows the molecular arrangement of atoms and bonds characteristic of travoprost.*
FDA Label Image

Travoprost-spl-2-5ml-bottle-label (Travoprost Spl 2 5ml Bottle Label)

Travoprost-spl-2-5ml-bottle-label (Travoprost Spl 2 5ml Bottle Label)
Label for Travoprost Ophthalmic Solution USP 0.004% (0.04 mg/mL) in a 2.6 mL bottle. The solution is an ionic buffered ophthalmic drop, sterile, and for prescription use only. Manufactured by Gland Pharma Limited, Hyderabad, India. Storage instructions specify 2°C to 25°C (36°F to 77°F) with a note for eye use only.*
FDA Label Image

Travoprost-spl-2-5ml-carton-label (Travoprost Spl 2 5ml Carton Label)

Travoprost-spl-2-5ml-carton-label (Travoprost Spl 2 5ml Carton Label)
Carton label for Travoprost Ophthalmic Solution, USP 0.004% (Ionic Buffered Solution) by Gland Pharma Limited. The ophthalmic solution is sterile and for eye use only, with a 2.5 mL volume. The label includes active ingredient information, storage instructions, and dosage directions. Barcode and manufacturer details are also present.*
FDA Label Image

Travoprost-spl-5ml-bottle-label (Travoprost Spl 5ml Bottle Label)

Travoprost-spl-5ml-bottle-label (Travoprost Spl 5ml Bottle Label)
Label for Travoprost Ophthalmic Solution USP 0.004% (0.04 mg/mL), a sterile 5 mL ophthalmic solution by Gland Pharma Limited. The label states storage conditions (2°C to 25°C), usage instructions for eye use only, standard dosing reference to insert, and includes manufacturer details with barcode.*
FDA Label Image

Travoprost-spl-5ml-carton-label (Travoprost Spl 5ml Carton Label)

Travoprost-spl-5ml-carton-label (Travoprost Spl 5ml Carton Label)
Box label for Travoprost Ophthalmic Solution USP 0.004% (0.04 mg/mL) sterile eye drops, supplied in a 5 mL bottle. The label indicates it is an ionic buffered solution for ophthalmic use only. Manufactured by Gland Pharma Limited, Hyderabad, India, with an NDC of 68083-602-01. Additional text includes inactive ingredients, storage instructions, and usage directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.